15.90

3.23% -0.53

After Hours: 15.90

Enanta Pharmaceuticals Inc (ENTA)

Overview News Price History Option Chain Financials Discussions Forecast

Enanta Pharmaceuticals Inc stock is traded at $15.90, with a volume of 342.82K. It is down -3.23% in the last 24 hours and up +12.61% over the past month. Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Previous Close:

$16.43

Open:

$16.42

24h Volume:

342.82K

Relative Volume:

0.46

Market Cap:

$458.92M

Revenue:

$66.59M

Net Income/Loss:

$-104.93M

P/E Ratio:

-3.2121

EPS:

-4.95

Net Cash Flow:

$-96.48M

1W Performance:

+1.21%

1M Performance:

+12.61%

6M Performance:

+110.32%

1Y Performance:

+171.79%

1-Day Range:

$15.80

$16.88

1-Week Range:

$15.80

$17.15

52-Week Range:

$4.09

$17.15

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name

Enanta Pharmaceuticals Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

617 607 0800

Address

4 KINGSBURY AVENUE, WATERTOWN, MA

Employee

120

Twitter

@EnantaPharma

Next Earnings Date

2025-02-10

Latest SEC Filings

ENTA's Discussions on Twitter

Compare ENTA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ENTA Enanta Pharmaceuticals Inc	15.90	474.21M	66.59M	-104.93M	-96.48M	-4.95
VRTX Vertex Pharmaceuticals Inc	453.74	116.65B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	773.94	82.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	397.25	52.69B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	837.90	51.56B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	174.09	37.61B	447.02M	-1.18B	-906.14M	-6.1812

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-25	Initiated	JP Morgan	Overweight
Oct-01-25	Upgrade	Jefferies	Hold → Buy
Jul-28-25	Resumed	H.C. Wainwright	Buy
Aug-09-23	Downgrade	JP Morgan	Neutral → Underweight
Aug-08-23	Downgrade	Jefferies	Buy → Hold
Dec-09-22	Initiated	H.C. Wainwright	Buy
Jul-06-22	Upgrade	Evercore ISI	In-line → Outperform
Jun-01-22	Upgrade	Evercore ISI	Underperform → In-line
Oct-07-21	Initiated	Jefferies	Buy
Sep-09-21	Initiated	SVB Leerink	Mkt Perform
Jan-29-21	Upgrade	JP Morgan	Underweight → Neutral
Nov-24-20	Initiated	Evercore ISI	Underperform
Aug-28-20	Resumed	ROTH Capital	Buy
Aug-26-20	Initiated	Piper Sandler	Overweight
Jul-27-20	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Mar-17-20	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-22-19	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-26-19	Downgrade	JP Morgan	Neutral → Underweight
May-24-19	Initiated	Wolfe Research	Outperform
Apr-23-19	Upgrade	Berenberg	Hold → Buy
Dec-13-18	Initiated	Berenberg	Hold
Jun-06-18	Initiated	ROTH Capital	Buy
Feb-08-18	Downgrade	JP Morgan	Overweight → Neutral
Jan-02-18	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-21-17	Reiterated	RBC Capital Mkts	Outperform
Sep-15-17	Initiated	RBC Capital Mkts	Outperform
Jul-11-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Apr-28-16	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Feb-09-16	Reiterated	Barclays	Underweight
Oct-23-15	Downgrade	Barclays	Equal Weight → Underweight
Oct-23-15	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform

View All

Enanta Pharmaceuticals Inc Stock (ENTA) Latest News

Dec 24, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 24, 2025

What makes Enanta Pharmaceuticals Inc. stock attractive to growth fundsTrend Following Strategies & Affordable Trading Portfolio - Bollywood Helpline

Dec 24, 2025

Dec 22, 2025

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains? - Yahoo Finance

Dec 22, 2025

Dec 21, 2025

What hedge fund activity signals for Enanta Pharmaceuticals Inc. stock2025 Market Outlook & Daily Growth Stock Investment Tips - Улправда

Dec 21, 2025

Dec 20, 2025

How Enanta Pharmaceuticals Inc. stock performs in interest rate cycles2025 Geopolitical Influence & Technical Pattern Recognition Alerts - Улправда

Dec 20, 2025

Does Enanta Pharmaceuticals Inc. stock trade at a discount to peersMarket Movement Recap & Smart Allocation Stock Tips - Улправда

Dec 20, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st

Dec 20, 2025

Rate Hike: Will Enanta Pharmaceuticals Inc. stock see insider buyingTrade Performance Summary & Daily Profit Focused Stock Screening - Улправда

Dec 20, 2025

Dec 19, 2025

Will Enanta Pharmaceuticals Inc. (9EP) stock see insider accumulationTrade Risk Report & Long-Term Safe Investment Ideas - Улправда

Dec 19, 2025

What margin trends mean for Enanta Pharmaceuticals Inc. stockJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда

Dec 19, 2025

Why Enanta Pharmaceuticals Inc. stock is considered a top pickMarket Activity Summary & Precise Trade Entry Recommendations - Улправда

Dec 19, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from upcoming earnings reportsRate Hike & Accurate Technical Buy Alerts - Bölüm Sonu Canavarı

Dec 19, 2025

Aug Breakouts: Will Enanta Pharmaceuticals Inc. (9EP) stock outperform Dow Jones2025 Market Sentiment & Weekly High Momentum Picks - Улправда

Dec 19, 2025

Is Enanta Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Retail & Low Drawdown Momentum Ideas - DonanımHaber

Dec 19, 2025

Will Enanta Pharmaceuticals Inc. stock benefit from automation2025 Earnings Impact & AI Based Buy/Sell Signal Reports - DonanımHaber

Dec 19, 2025

Will Enanta Pharmaceuticals Inc. stock see insider buyingMarket Trend Report & Fast Exit and Entry Strategy Plans - Улправда

Dec 19, 2025

Why Enanta Pharmaceuticals Inc. stock appeals to analystsStop Loss & Expert Approved Trade Ideas - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Is Enanta Pharmaceuticals Inc. stock trading at a premium valuation2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда

Dec 18, 2025

Dec 15, 2025

(ENTA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Dec 15, 2025

Dec 13, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat

Dec 13, 2025

Dec 08, 2025

Have Insiders Sold Enanta Pharmaceuticals Shares Recently? - simplywall.st

Dec 08, 2025

Enanta Pharmaceuticals falls on public offering of common stock - MSN

Dec 08, 2025

Dec 06, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Scott Rottinghaus Sells 798 Shares - MarketBeat

Dec 06, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay Luly Sells 4,743 Shares of Stock - MarketBeat

Dec 06, 2025

Enanta Pharma chief medical officer sells $11k in stock By Investing.com - Investing.com Canada

Dec 06, 2025

Tara Lynn Kieffer Sells 2,106 Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) Stock - MarketBeat

Dec 06, 2025

Dec 05, 2025

Enanta Pharma CBO Luu sells $19,836 in stock By Investing.com - Investing.com Canada

Dec 05, 2025

Enanta Pharma CBO Luu sells $19,836 in stock - Investing.com India

Dec 05, 2025

Enanta Pharma CSO Or Yat Sun sells $34k in stock - Investing.com India

Dec 05, 2025

Enanta Pharma CSO Or Yat Sun sells $34k in stock By Investing.com - Investing.com South Africa

Dec 05, 2025

Enanta Pharma chief product officer sells $30k in stock By Investing.com - Investing.com UK

Dec 05, 2025

Will Enanta Pharmaceuticals Inc. (9EP) stock extend growth storyJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser

Dec 05, 2025

Dec 04, 2025

Can Enanta Pharmaceuticals Inc. (9EP) stock survive global slowdownJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser

Dec 04, 2025

Is Enanta Pharmaceuticals Inc. (9EP) stock nearing a technical breakout - Newser

Dec 04, 2025

Is Enanta Pharmaceuticals Inc. stock a top momentum playQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025

Dec 03, 2025

VP Or Surrenders 753 Of Enanta Pharmaceuticals Inc [ENTA] - TradingView

Dec 03, 2025

ENTA: RSV and immunology pipelines advance with key candidates and pivotal trials planned for 2026 - TradingView

Dec 03, 2025

Dec 02, 2025

Is Enanta Pharmaceuticals Inc. (9EP) stock a defensive play amid uncertainty - Newser

Dec 02, 2025

Nov 30, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 30, 2025

Nov 29, 2025

Certain Options of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com

Nov 29, 2025

Certain Common Stock of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com

Nov 29, 2025

Portfolio Recap: What makes Enanta Pharmaceuticals Inc. stock attractive to growth funds2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - moha.gov.vn

Nov 29, 2025

Enanta Pharmaceuticals Inc Stock Analysis and ForecastMarket Capitalization Trends & Free Unmatched Market Performance - earlytimes.in

Nov 29, 2025

Nov 27, 2025